Reston – February 23, 2017 – Cooley is advising longstanding client Invincea on its pending sale to Sophos (LSE: SOPH), an Oxford, UK-based global leader in network and endpoint security, for up to $120 million.
Invincea, founded in 2009 and based in Fairfax, Virginia, is a next-generation endpoint security company, whose portfolio of solutions is designed to detect and prevent unknown malware and sophisticated attacks via its patented deep learning neural-network algorithms. Invincea was named a “Visionary” in the 2017 Gartner Magic Quadrant report on Global MSSPs, and it is ranked among the best performing machine learning endpoint technologies.
“Sophos is recognized as a leader in endpoint protection today with an expanding set of next-generation technologies such as the signature-less anti-malware, anti-exploit and anti-ransomware technology in Intercept X and the behavior-based analytics, Malicious Traffic Detection and Application Reputation in Sophos Endpoint Protection,” said Anup Ghosh, founder and chief executive officer of Invincea. “X by Invincea represents a new generation in antivirus technology based on deep learning and behavioral monitoring. Joining forces with Sophos presents the perfect opportunity to take our proven, advanced technology to a global audience and make it part of a comprehensive synchronized security system. Sophos is leading the industry in adopting and bringing to market this disruptive new vision for complete, advanced, and integrated security, and we are delighted to join the team and help make it happen.”
Closing of the transaction is subject to satisfaction of various closing conditions.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 900 lawyers across 12 offices in the United States, China and Europe.